US pharmaceutical stocks extend gains, AstraZeneca rises over 6% after earnings

According to MSX.COM data, US pharmaceutical stocks extended their gains. AstraZeneca rose over 6% after its earnings report, with Q3 profit exceeding expectations; Eli Lilly and Gilead Sciences rose over 4%, Amgen gained nearly 3%, and Johnson & Johnson rose nearly 2%, with all hitting record intraday highs.